trial

EEG Microstates Across At-Risk Mental States

NCTId NCT06045897
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 126 (estimated)
Sponsored by Centre Hospitalier St Anne
Primary completion 2026-07-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
126 (estimated)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
None
Start
2023-05-30
Primary completion
2026-07-30
Eligibility
ALL · 15 Years · 30 Years

Interventions & indications

Drugs
EEG 64 channelsPolysomnography 19 electrodesLight hypnosisBiological samplingVirtual realityVoice recording

Sponsors

Centre Hospitalier St AnneLead Sponsor
Assistance Publique - Hôpitaux de ParisCollaborator

Investigators

1
Anton Iftimovici, MD, PhDPrincipal Investigator

Sites

1 total
Paris, France

Facts & assertions

4 sourced
Enrollment
126
Phase
NA
Primary Completion Date
2026-07-30
Status
RECRUITING
relationships
The graph out of here
drug
EEG 64 channels
drug
Polysomnography 19 electrodes
drug
Light hypnosis
drug
Biological sampling
drug
Virtual reality
drug
Voice recording
drug
lead_sponsor
Centre Hospitalier St Anne
company
collaborator
Assistance Publique - Hôpitaux de Paris
company
indication
Autism Spectrum Disorder
indication
Psychotic Disorders
indication
Major Depressive Disorder
indication
investigator
Anton Iftimovici, MD, PhD
person